Jonathan T. Allan Soros, 10% Owner at MAP Pharmaceuticals, Inc. (MAPP), sold 206,726 shares at $14.15 ($2.9M) on 2010-03-04, disclosed to the SEC on 2010-03-08.
Open-market sale of $2.9M MAPP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.09 | 2,503 | $35K | 1.2% |
| 2 | $14.09 | 97 | $1K | 0.0% |
| 3 | $14.15 | 677 | $10K | 0.3% |
| 4 | $14.15 | 3,061 | $43K | 1.5% |
| 5 | $13.95 | 168,376 | $2.3M | 81.4% |
| 6 | $13.95 | 4,616 |
| $64K |
| 2.2% |
| 7 | $13.95 | 6,524 | $91K | 3.2% |
| 8 | $13.95 | 20,872 | $291K | 10.1% |
| Total | $13.96 avg | 206,726 | $2.9M | 100% |
| Filing → |
| EXAR | BUY | 2011-03-08 | $126K | — | Filing → |
| EXAR | BUY | 2011-01-27 | $140K | — | Filing → |